📰 Abt News
Page 204 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
March 14, 2022
Swarthmore Group Inc. trimmed its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 5.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,512 shares of the healthcare product maker’s stock after selling 2,575 shares during the quarter. […]
March 14, 2022
Sippican Capital Advisors trimmed its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 13.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,727 shares of the healthcare product maker’s stock after selling 900 shares during the quarter. Sippican Capital Advisors’ holdings in […]
March 11, 2022
M&G Investment Management Ltd. reduced its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 88.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 91,961 shares of the healthcare product maker’s stock after selling 693,391 shares during the period. M&G Investment Management Ltd.’s […]
March 10, 2022
DeDora Capital Inc. increased its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 3.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 14,533 shares of the healthcare product maker’s stock after acquiring an additional 486 shares during the period. Abbott Laboratories accounts for 1.2% of DeDora Capital Inc.’s holdings, making the […]
March 9, 2022
Farmers & Merchants Investments Inc. trimmed its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 1.7% in the fourth quarter, Holdings Channel reports. The fund owned 178,251 shares of the healthcare product maker’s stock after selling 3,071 shares during the period. Abbott Laboratories accounts for about 0.9% of Farmers & Merchants Investments […]
March 9, 2022
Relyea Zuckerberg Hanson LLC lessened its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 28.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,956 shares of the healthcare product maker’s stock after selling 773 shares during the period. Relyea Zuckerberg […]
March 9, 2022
Mraz Amerine & Associates Inc. lowered its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 0.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,814 shares of the healthcare product maker’s stock after selling 92 shares during the […]
March 8, 2022
Sawyer & Company Inc reduced its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 0.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,948 shares of the healthcare product maker’s stock after selling 106 shares […]
March 8, 2022
Five Oceans Advisors raised its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 4.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,009 shares of the healthcare product maker’s stock after buying an additional 122 […]
March 7, 2022
Abbott Laboratories (NYSE:ABT – Get Rating) issued an update on its FY 2022 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $4.700-$ for the period, compared to the Thomson Reuters consensus estimate of $4.850. The company issued revenue guidance of -. ABT stock traded down $1.57 during trading on […]